Oncofertility is an interdisciplinary field at the intersection of oncology and reproductive medicine that expands fertility options for young cancer survivors. Experts in this field identify which cancer treatments are likely to damage later reproductive ability for men, women, and children and develop new fertility preservation methods. In addition, these scientists are also identifying cancer treatments that may be “fertoprotective” and prevent damage to the reproductive organs during cancer treatment. Every year, experts in this field meet to discuss the recent advances in oncofertility scientific and medical treatment. The sixth annual conference is September 27 - 28, 2012 in Chicago, IL.
The program for this two-day conference on fertility after cancer features translational and clinical research on fertility preservation, lessons learned from individual fertility preservation programs, a speech and special performance by the founder of the adolescent and young adult cancer advocacy group, Stupid Cancer, and a Keynote Symposium by Hamish Wallace, MD (Royal Hospital for Sick Children, Edinburgh). During the two days of the conference, more than 20 invited speakers from across the globe will present cutting-edge information to attendees.
Health care providers will be provided with CME or nursing contact hours at no additional cost. For more information or to register for the conference, visit the website at http://bit.ly/oncofert12 or email email@example.com. The 2012 Oncofertility Conference is funded by the NIH (Grant 5R13HD063248-03), and an unrestricted educational grant from Ferring Pharmaceuticals, Inc.
To learn more about fertility and cancer, visit SaveMyFertility.org and download the free iPhone app.